SNCA and Parkinson disease: In addition, increased SNCA mRNA was observed predominantly in the midbrain or substantia nigra of patients with PD [8], while a decrease is detected in other tissues and regions, such as temporal and frontal cortexes and cerebrospinal fluid [9].